Observational studyHematological oncology2025

Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results.

Prokop Vodicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.